Abemaciclib as initial therapy for advanced breast cancer: MONARCH 3 updated results in prognostic subgroups
Johnston S, Hardebeck M, Martin H, Andre V, Sohn J, Toi M, Huober J, Martín M, O'Shaughnessy J, Goetz M. Abemaciclib as initial therapy for advanced breast cancer: MONARCH 3 updated results in prognostic subgroups. NPJ Breast Cancer 2021; 7:80.
22.06.2021
Abemaciclib as initial therapy for advanced breast cancer: MONARCH 3 updated results in prognostic subgroups
22.06.2021
NPJ Breast Cancer 2021; 7:80
Johnston Stephen, Hardebeck Molly C, Martin Holly R, Andre Valerie A M, Sohn Joohyuk, Toi Masakazu, Huober Jens, Martín Miguel, O'Shaughnessy Joyce, Goetz Matthew P
Weiter
